Estimation of Willingness-to-Pay for breast cancer treatments through Contingent Valuation Method in Japanese breast cancer patients(JCOG1709A)
Not Applicable
Recruiting
- Conditions
- 1)Unilateral breast cancer patients who fulfill either i) or ii) below i)Primary breast cancer of clinical stage 0 through III for which surgery and /or chemotherapy and / or radiotherapy has been completed as initial treatment and that is currently undergoing regular follow-up observations or postoperative endocrine therapy ii)Undergoing endocrine therapy or first-line through third-line chemotherapy for metastatic or recurrent cancer for at least 2 months
- Registration Number
- JPRN-UMIN000037445
- Lead Sponsor
- Japan Clinical Oncology Group (JCOG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 1764
Inclusion Criteria
Not provided
Exclusion Criteria
Nothing
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method